GlaxoSmithKline signed a potential $1 billion deal with U.S. biotech company Concert Pharmaceuticals to develop drugs that use deuterium, a chemical that could improve how some medicines work. The collaboration will beef up GlaxoSmithKline's pipeline of early stage drugs.
Comment on GlaxoSmithKline teams up with biotech company
SignOnSanDiego.com: Business, San Diego Union-Tribune: Business
Wed, 06/03/2009 - 2:00am
Welcome to Wopular
Wopular is an
online newspaper rack,
giving you a summary view of the top headlines from the top news sites.
Senh Duong (Founder)
Wopular,
MWB,
RottenTomatoes
MoviesWithButter : Our Sister Site
- "Expendables 4" Starts Shooting This Fall, Says Randy Couture at the Arnold Sports Festival more
- “Expendables 4” Gets Funding Interest from “Ip Man 3” Financier more
- "Ip Man 3" Distributor Suspected of Box Office Fraud, Parent Company Loses $200M in Market Cap more
- Yen Targets "Ip Man 4" for 2018 Release; Discusses Film with Director, Producer more
- "Ip Man 3" Shatters Expectations with $72M Opening [China Box Office] more